Cargando…

CRISPR-Cas System: A Tool to Eliminate Drug-Resistant Gram-Negative Bacteria

Rapidly emerging drug-resistant superbugs, especially Gram-negative bacteria, pose a serious threat to healthcare systems all over the globe. Newer strategies are being developed to detect and overcome the arsenal of weapons that these bacteria possess. The development of antibiotics is time-consumi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kundar, Rajeshwari, Gokarn, Karuna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781512/ https://www.ncbi.nlm.nih.gov/pubmed/36558949 http://dx.doi.org/10.3390/ph15121498

Ejemplares similares

Activity of siderophores against drug-resistant Gram-positive and Gram-negative bacteria
por: Gokarn, Karuna, et al.
Publicado: (2018)

Epidemiology and Mechanisms of Resistance of Extensively Drug Resistant Gram-Negative Bacteria
por: Eichenberger, Emily M., et al.
Publicado: (2019)

Mechanisms of Antimicrobial Peptide Resistance in Gram-Negative Bacteria
por: Band, Victor I., et al.
Publicado: (2014)

Evaluation of Antibiotic Resistance Mechanisms in Gram-Negative Bacteria
por: Gauba, Anusha, et al.
Publicado: (2023)

Application of different types of CRISPR/Cas-based systems in bacteria
por: Liu, Zhenquan, et al.
Publicado: (2020)

Drug Inducible CRISPR/Cas Systems
por: Zhang, Jingfang, et al.
Publicado: (2019)

Antibiotic Resistance of Gram-Negative Bacteria in Rivers, United States
por: Ash, Ronald J., et al.
Publicado: (2002)

Optimizing Polymyxin Combinations Against Resistant Gram-Negative Bacteria
por: Bergen, Phillip J., et al.
Publicado: (2015)

Multidrug Resistant Gram-Negative Bacteria in Community-Acquired Pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2019)

Relationship between Virulence and Resistance among Gram-Negative Bacteria
por: Cepas, Virginio, et al.
Publicado: (2020)

Antimicrobial Peptides: Virulence and Resistance Modulation in Gram-Negative Bacteria
por: Duperthuy, Marylise
Publicado: (2020)

Clinical Status of Efflux Resistance Mechanisms in Gram-Negative Bacteria
por: Davin-Regli, Anne, et al.
Publicado: (2021)

Application of the CRISPR/Cas9 System to Drug Resistance in Breast Cancer
por: Chen, Yinnan, et al.
Publicado: (2018)

Genome Editing in Bacteria: CRISPR-Cas and Beyond
por: Arroyo-Olarte, Ruben D., et al.
Publicado: (2021)

Targeted elimination of Vancomycin resistance gene vanA by CRISPR-Cas9 system
por: Tao, Shuan, et al.
Publicado: (2023)

Editorial: CRISPR-Cas Systems in Bacteria and Archaea
por: Kamruzzaman, Muhammad, et al.
Publicado: (2022)

Phosphoethanolamine Transferases as Drug Discovery Targets for Therapeutic Treatment of Multi-Drug Resistant Pathogenic Gram-Negative Bacteria
por: Thai, Van C., et al.
Publicado: (2023)

Combination antibiotic therapy for multidrug-resistant Gram-negative bacteria
por: Tängdén, Thomas
Publicado: (2014)

Preliminary evaluation of anti-tuberculosis potential of siderophores against drug-resistant Mycobacterium tuberculosis by mycobacteria growth indicator tube-drug sensitivity test
por: Gokarn, Karuna, et al.
Publicado: (2017)

Challenges in antibiotic resistance: Gram negative bacteria
Publicado: (2020)

Presence & mobility of antimicrobial resistance in Gram-negative bacteria from environmental samples in coastal Karnataka, India
por: Mohan Raj, Juliet Roshini, et al.
Publicado: (2019)

The Application of the CRISPR-Cas System in Antibiotic Resistance
por: Tao, Shuan, et al.
Publicado: (2022)

Resistance of Gram-Negative Bacteria to Current Antibacterial Agents and Approaches to Resolve It
por: Breijyeh, Zeinab, et al.
Publicado: (2020)

Outer Membrane Porins Contribute to Antimicrobial Resistance in Gram-Negative Bacteria
por: Zhou, Gang, et al.
Publicado: (2023)

Infections Caused by Antimicrobial Drug-Resistant Saprophytic Gram-Negative Bacteria in the Environment
por: Raphael, Eva, et al.
Publicado: (2017)

Novel Immunization Strategies Against Multi-drug-resistant Gram-negative Bacteria
por: Youssef, Eman A, et al.
Publicado: (2017)

Screening for multi-drug-resistant Gram-negative bacteria: what is effective and justifiable?
por: Nijsingh, Niels, et al.
Publicado: (2020)

Bacteriophage as a Novel Therapeutic Weapon for Killing Colistin-Resistant Multi-Drug-Resistant and Extensively Drug-Resistant Gram-Negative Bacteria
por: Mousavi, Seyed Mohammad, et al.
Publicado: (2021)

Actin Crosslinking Toxins of Gram-Negative Bacteria
por: Satchell, Karla J. F.
Publicado: (2009)

Bifurcation kinetics of drug uptake by Gram-negative bacteria
por: Westfall, David A., et al.
Publicado: (2017)

The Challenge of Overcoming Antibiotic Resistance in Carbapenem-Resistant Gram-Negative Bacteria: “Attack on Titan”
por: Mancuso, Giuseppe, et al.
Publicado: (2023)

Molecular basis of active copper resistance mechanisms in Gram-negative bacteria
por: Bondarczuk, Kinga, et al.
Publicado: (2013)

CRISPR/Cas9 System as an Agent for Eliminating Polyomavirus JC Infection
por: Wollebo, Hassen S., et al.
Publicado: (2015)

Imipenem Resistance among Gram-Negative and Gram-Positive Bacteria in Hospitalized Patients
por: Khorshidi, A, et al.
Publicado: (2010)

Virulence-associated type III secretion systems in Gram-negative bacteria
por: Pais, Sara Vilela, et al.
Publicado: (2023)

Current trends in the treatment of pneumonia due to multidrug-resistant Gram-negative bacteria
por: Watkins, Richard R., et al.
Publicado: (2019)

The threat of carbapenem-resistant gram-negative bacteria in a Middle East region
por: Davoudi-Monfared, Effat, et al.
Publicado: (2018)

Treatment of Bloodstream Infections Due to Gram-Negative Bacteria with Difficult-to-Treat Resistance
por: Bassetti, Matteo, et al.
Publicado: (2020)

An Update on Eight “New” Antibiotics against Multidrug-Resistant Gram-Negative Bacteria
por: Yusuf, Erlangga, et al.
Publicado: (2021)

Polymyxin E–Resistant Gram-Negative Bacteria in Tunisia and Neighboring Countries: Are There Commonalities?
por: Dziri, Olfa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_urfndqse42ium31sgpnf2uvdj7